Highlights
NASDAQ: BPMC       Blueprint Medicines Corp
Last Price Today's Change   Day's Range   Trading Volume
74.25   +0.49 (0.66%)  73.02 - 75.08  296,100

Overview

 
Avg Volume (4 weeks):506,800
4 Weeks Range:69.43 - 83.00
4 Weeks Price Volatility (%):
35.52%
52 Weeks Range:44.577 - 102.98
52 Weeks Price Volatility (%):
50.81%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers